The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...
If you smoke and want to quit, call the national quit line at 1-800-784-8669 to speak with a confidential coach. In what ...
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...
Developing slowly over months to years, feline small cell gastrointestinal (GI) lymphoma can be difficult to detect. 1 With this type of cancer resembling many of the common digestive issues cats ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...
The TellDx CTC iChip platform enables high-efficiency isolation of intact circulating tumor cells without reliance on cell size or epithelial markers. This unbiased approach is particularly well ...
The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...
10don MSN
Boosting the cell's own cleanup: New class of small molecules accelerate natural protein degradation
Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in ...
Researchers have just uncovered a hidden inflammatory mechanism that could be the key. In this short video, we break down a ...
News Medical on MSN
Study: ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results